Receptor complementation and mutagenesis reveal SR-BI as an essential HCV entry factor and functionally imply its intra- and extra-cellular domains

PLoS Pathogens

Volumn 5, Issue 2, 2009, Pages

  Dreux, Marlène ^a   Thi, Viet Loan Dao ^a   Fresquet, Judith ^a   Guérin, Maryse ^b   Julia, Zélie ^b   Verney, Géraldine ^a   Durantel, David ^a   Zoulim, Fabien ^a   Lavillette, Dimitri ^a   Cosset, François Loïc ^a   Bartosch, Birke ^a  

^a UNIVERSITÉ LYON 1   (France)

^b INSERM   (France)

Author keywords

[No Author keywords available]

Indexed keywords

HIGH DENSITY LIPOPROTEIN; SCAVENGER RECEPTOR BI; VIRUS RECEPTOR; CD81 ANTIGEN; CLAUDIN 1; HYBRID PROTEIN; LEUKOCYTE ANTIGEN; MEMBRANE PROTEIN; SCARB1 PROTEIN, HUMAN; SCARB1 PROTEIN, RAT; SCAVENGER RECEPTOR B;

ANIMAL CELL; ARTICLE; CHOLESTEROL TRANSPORT; CONTROLLED STUDY; HEPATOMA CELL; HUMAN; HUMAN CELL; HUMAN CYTOMEGALOVIRUS; MUTAGENESIS; NONHUMAN; NUCLEOTIDE SEQUENCE; PROTEIN DOMAIN; PROTEIN EXPRESSION; RAT; VIRUS ATTACHMENT; VIRUS ENTRY; VIRUS INFECTIVITY; ANIMAL; CELL LINE; CHO CELL; CRICETULUS; DOG; GENETICS; HAMSTER; HEPATITIS C VIRUS; METABOLISM; MOUSE; PROTEIN TERTIARY STRUCTURE; TUMOR CELL LINE;

HEPATITIS C VIRUS; RATTUS;

ANIMALS; ANTIGENS, CD; CELL LINE; CELL LINE, TUMOR; CHO CELLS; CRICETINAE; CRICETULUS; DOGS; HEPACIVIRUS; HUMANS; MEMBRANE PROTEINS; MICE; MUTAGENESIS; PROTEIN STRUCTURE, TERTIARY; RATS; RECEPTORS, VIRUS; RECOMBINANT FUSION PROTEINS; SCAVENGER RECEPTORS, CLASS B; VIRUS INTERNALIZATION;

EID: 61449203893     PISSN: 15537366     EISSN: 15537374     Source Type: Journal    
DOI: 10.1371/journal.ppat.1000310     Document Type: Article

References (84)

1. Shepard CW, Finelli L, Alter MJ (2005) Global epidemiology of hepatitis C virus infection. Lancet Infect Dis 5: 558-567.
2. Bartosch B, Cosset F-L (2006) Cell entry of hepatitis C virus. Virology 348: 1-12.
3. Dubuisson J, Helle F, Cocquerel L (2008) Early steps of the hepatitis C virus life cycle. Cell Microbiol 10: 821-827.
4. von Hahn T, Rice CM (2008) Hepatitis C virus entry. J Biol Chem 283: 3689-3693.
5. Thomssen R, Bonk S, Propfe C, Heermann KH, Kochel HG, et al. (1992) Association of hepatitis C virus in human sera with beta-lipoprotein. Med Microbiol Immunol 181: 293-300.
6. Agnello V, Abel G, Elfahal M, Knight GB, Zhang QX (1999) Hepatitis C virus and other flaviviridae viruses enter cells via low density lipoprotein receptor. Proc Natl Acad Sci U S A 96: 12766-12771.
7. Scarselli E, Ansuini H, Cerino R, Roccasecca R, Acali S, et al. (2002) The human scavenger receptor class B type I is a novel candidate receptor for the hepatitis C virus. EMBO J 21: 5017-5025.
8. Pileri P, Uematsu Y, Campagnoli S, Galli G, Falugi F, et al. (1998) Binding of hepatitis C virus to CD81. Science 282: 938-941.
9. Evans MJ, von Hahn T, Tscherne DM, Syder AJ, Panis M, et al. (2007) Claudin-1 is a hepatitis C virus co-receptor required for a late step in entry. Nature 446: 801-805.
10. Blanchard E, Belouzard S, Goueslain L, Wakita T, Dubuisson J, et al. (2006) Hepatitis C virus entry depends on clathrin-mediated endocytosis. J Virol 80: 6964-6972.
11. Meertens L, Bertaux C, Dragic T (2006) Hepatitis C virus entry requires a critical postinternalization step and delivery to early endosomes via clathrin-coated vesicles. J Virol 80: 11571-11578.
12. Bartosch B, Vitelli A, Granier C, Goujon C, Dubuisson J, et al. (2003) Cell entry of hepatitis C virus requires a set of co-receptors that include the CD81 tetraspanin and the SR-B1 scavenger receptor. J Biol Chem 278: 41624-41630.
13. Hsu M, Zhang J, Flint M, Logvinoff C, Cheng-Mayer C, et al. (2003) Hepatitis C virus glycoproteins mediate pH-dependent cell entry of pseudotyped retroviral particles. Proc Natl Acad Sci U S A 100: 7271-7276.
14. Lavillette D, Tarr AW, Voisset C, Donot P, Bartosch B, et al. (2005) Characterization of host-range and cell entry properties of hepatitis C virus of major genotypes and subtypes. Hepatology 41: 265-274.
15. Lavillette D, Bartosch B, Nourrisson D, Verney G, Cosset FL, et al. (2006) Hepatitis C Virus Glycoproteins Mediate Low pH-dependent Membrane Fusion with Liposomes. J Biol Chem 281: 3909-3917.
16. Tscherne DM, Jones CT, Evans MJ, Lindenbach BD, McKeating JA, et al. (2006) Time- and temperature-dependent activation of hepatitis C virus for low-pH-triggered entry. J Virol 80: 1734-1741.
17. Kielian M, Rey FA (2006) Virus membrane-fusion proteins: more than one way to make a hairpin. Nat Rev Microbiol 4: 67-76.
18. Calvo D, Vega MA (1993) Identification, primary structure, and distribution of CLA-1, a novel member of the CD36/LIMPII gene family. J Biol Chem 268: 18929-18935.
19. Webb NR, Connell PM, Graf GA, Smart EJ, de Villiers WJ, et al. (1998) SR-BII, an isoform of the scavenger receptor BI containing an alternate cytoplasmic tail, mediates lipid transfer between high density lipoprotein and cells. J Biol Chem 273: 15241-15248.
20. Krieger M (2001) Scavenger receptor class B type I is a multiligand HDL receptor that influences diverse physiologic systems. J Clin Invest 108: 793-797.
21. Silver DL, Wang N, Xiao X, Tall AR (2001) High density lipoprotein (HDL) particle uptake mediated by scavenger receptor class B type 1 results in selective sorting of HDL cholesterol from protein and polarized cholesterol secretion. J Biol Chem 276: 25287-25293.
22. Parathath S, Connelly MA, Rieger RA, Klein SM, Abumrad NA, et al. (2004) Changes in plasma membrane properties and phosphatidylcholine subspecies of insect Sf9 cells due to expression of scavenger receptor class B, type I, and CD36. J Biol Chem 279: 41310-41318.
23. Kellner-Weibel G, de La Llera-Moya M, Connelly MA, Stoudt G, Christian AE, et al. (2000) Expression of scavenger receptor BI in COS-7 cells alters cholesterol content and distribution. Biochemistry 39: 221-229.
24. Maillard P, Huby T, Andreo U, Moreau M, Chapman J, et al. (2006) The interaction of natural hepatitis C virus with human scavenger receptor SR-BI/Cla1 is mediated by ApoB-containing lipoproteins. Faseb J 20: 735-737.
25. Bartosch B, Verney G, Dreux M, Donot P, Morice Y, et al. (2005) An interplay between hypervariable region 1 of the hepatitis C virus E2 glycoprotein, the scavenger receptor BI, and high-density lipoprotein promotes both enhancement of infection and protection against neutralizing antibodies. J Virol 79: 8217-8229.
26. Catanese MT, Graziani R, von Hahn T, Moreau M, Huby T, et al. (2007) High avidity monoclonal antibodies against human scavenger receptor class B type I efficiently block hepatitis C virus infection in the presence of HDL. J Virol 81: 8063-8071.
27. Dreux M, Pietschmann T, Granier C, Voisset C, Ricard-Blum S, et al. (2006) High density lipoprotein inhibits hepatitis C virus neutralising antibodies by stimulating cell entry via activation of the scavenger receptor BI. J Biol Chem 281: 18285-18295.
28. Meunier JC, Engle RE, Faulk K, Zhao M, Bartosch B, et al. (2005) Evidence for cross-genotype neutralization of hepatitis C virus pseudo-particles and enhancement of infectivity by apolipoprotein C1. Proc Natl Acad Sci U S A 102: 4560-4565.
29. Voisset C, Callens N, Blanchard E, Op De Beeck A, Dubuisson J, et al. (2005) High density lipoproteins facilitate hepatitis C virus entry through the scavenger receptor class B type I. J Biol Chem 280: 7793-7799.
30. Voisset C, Op de Beeck A, Horellou P, Dreux M, Gustot T, et al. (2006) High-density lipoproteins reduce the neutralizing effect of hepatitis C virus (HCV)-infected patient antibodies by promoting HCV entry. J Gen Virol 87: 2577-2581.
31. Randall G, Panis M, Cooper JD, Tellinghuisen TL, Sukhodolets KE, et al. (2007) Cellular cofactors affecting hepatitis C virus infection and replication. Proc Natl Acad Sci U S A 104: 12884-12889.
32. Zeisel MB, Koutsoudakis G, Schnober EK, Haberstroh A, Blum HE, et al. (2007) Scavenger receptor class B type I is a key host factor for hepatitis C virus infection required for an entry step closely linked to CD81. Hepatology 46: 1722-1731.
33. Bartosch B, Dubuisson J, Cosset FL (2003) Infectious hepatitis C virus pseudoparticles containing functional E1-E2 envelope protein complexes. J Exp Med 197: 633-642.
34. vonHahn T, Lindenbach BD, Boullier A, Quehenberger O, Paulson M, et al. (2006) Oxidized low density lipoprotein inhibits hepatitis C virus cell entry. Hepatology 43: 932-942.
35. Dreux M, Boson B, Ricard-Blum S, Molle J, Lavillette D, et al. (2007) The exchangeable apolipoprotein ApoC-I promotes membrane fusion of hepatitis C virus. J Biol Chem 282: 32357-32369.
36. Le Goff W, Settle M, Greene DJ, Morton RE, Smith JD (2006) Reevaluation of the role of the multidrug-resistant P-glycoprotein in cellular cholesterol homeostasis. J Lipid Res 47: 51-58.
37. de la Llera Moya M, Atger V, Paul JL, Fournier N, Moatti N, et al. (1994) A cell culture system for screening human serum for ability to promote cellular cholesterol efflux. Relations between serum components and efflux, esterification, and transfer. Arterioscler Thromb 14: 1056-1065.
38. Flint M, Maidens C, Loomis-Price LD, Shotton C, Dubuisson J, et al. (1999) Characterization of hepatitis C virus E2 glycoprotein interaction with a putative cellular receptor, CD81. J Virol 73: 6235-6244.
39. Owsianka AM, Timms JM, Tarr AW, Brown RJ, Hickling TP, et al. (2006) Identification of conserved residues in the E2 envelope glycoprotein of the hepatitis C virus that are critical for CD81 binding. J Virol 80: 8695-8704.
40. Owsianka A, Clayton RF, Loomis-Price LD, McKeating JA, Patel AH (2001) Functional analysis of hepatitis C virus E2 glycoproteins and virus-like particles reveals structural dissimilarities between different forms of E2. J Gen Virol 82: 1877-1883.
41. Zhang J, Randall G, Higginbottom A, Monk P, Rice CM, et al. (2004) CD81 is required for hepatitis C virus glycoprotein-mediated viral infection. J Virol 78: 1448-1455.
42. Bertaux C, Dragic T (2006) Different domains of CD81 mediate distinct stages of hepatitis C virus pseudoparticle entry. J Virol 80: 4940-4948.
43. Lavillette D, Pécheur E-I, Donot P, Fresquet J, Molle J, et al. (2007) Characterization of fusion determinants points to the involvement of three discrete regions of both E1 and E2 glycoproteins in the membrane fusion process of hepatitis C virus. J Virol 81: 8752-8765.
44. Connelly MA, Klein SM, Azhar S, Abumrad NA, Williams DL (1999) Comparison of class B scavenger receptors, CD36 and scavenger receptor BI (SR-BI), shows that both receptors mediate high density lipoprotein-cholesteryl ester selective uptake but SR-BI exhibits a unique enhancement of cholesteryl ester uptake. J Biol Chem 274: 41-47.
45. Connelly MA, de la Llera-Moya M, Monzo P, Yancey PG, Drazul D, et al. (2001) Analysis of chimeric receptors shows that multiple distinct functional activities of scavenger receptor, class B, type I (SR-BI), are localized to the extracellular receptor domain. Biochemistry 40: 5249-5259.
46. Gu X, Trigatti B, Xu S, Acton S, Babitt J, et al. (1998) The efficient cellular uptake of high density lipoprotein lipids via scavenger receptor class B type I requires not only receptor-mediated surface binding but also receptor-specific lipid transfer mediated by its extracellular domain. J Biol Chem 273: 26338-26348.
47. Eckhardt ER, Cai L, Sun B, Webb NR, van der Westhuyzen DR (2004) High density lipoprotein uptake by scavenger receptor SR-BII. J Biol Chem 279: 14372-14381.
48. Mulcahy JV, Riddell DR, Owen JS (2004) Human scavenger receptor class B type II (SR-BII) and cellular cholesterol efflux. Biochem J 377: 741-747.
49. Ikemoto M, Arai H, Feng D, Tanaka K, Aoki J, et al. (2000) Identification of a PDZ-domain-containing protein that interacts with the scavenger receptor class B type I. Proc Natl Acad Sci U S A 97: 6538-6543.
50. Komori H, Arai H, Kashima T, Huby T, Kita T, et al. (2008) Coexpression of CLA-1 and Human PDZK1 in Murine Liver Modulates HDL Cholesterol Metabolism. Arterioscler Thromb Vasc Biol 28: 1298-1303.
51. Eckhardt ER, Cai L, Shetty S, Zhao Z, Szanto A, et al. (2006) High density lipoprotein endocytosis by scavenger receptor SR-BII is clathrin-dependent and requires a carboxyl-terminal dileucine motif. J Biol Chem 281: 4348-4353.
52. Gu X, Kozarsky K, Krieger M (2000) Scavenger receptor class B, type I-mediated [3H]cholesterol efflux to high and low density lipoproteins is dependent on lipoprotein binding to the receptor. J Biol Chem 275: 29993-30001.
53. Nieland TJ, Penman M, Dori L, Krieger M, Kirchhausen T (2002) Discovery of chemical inhibitors of the selective transfer of lipids mediated by the HDL receptor SR-BI. Proc Natl Acad Sci U S A 99: 15422-15427.
54. Gu X, Lawrence R, Krieger M (2000) Dissociation of the high density lipoprotein and low density lipoprotein binding activities of murine scavenger receptor class B type I (mSR-BI) using retrovirus library-based activity dissection. J Biol Chem 275: 9120-9130.
55. Vinals M, Xu S, Vasile E, Krieger M (2003) Identification of the N-linked glycosylation sites on the high density lipoprotein (HDL) receptor SR-BI and assessment of their effects on HDL binding and selective lipid uptake. J Biol Chem 278: 5325-5332.
56. Connelly MA, De La Llera-Moya M, Peng Y, Drazul-Schrader D, Rothblat GH, et al. (2003) Separation of lipid transport functions by mutations in the extracellular domain of scavenger receptor class B, type I. J Biol Chem 278: 25773-25782.
57. Parathath S, Sahoo D, Darlington YF, Peng Y, Collins HL, et al. (2004) Glycine 420 near the C-terminal transmembrane domain of SR-BI is critical for proper delivery and metabolism of high density lipoprotein cholesteryl ester. J Biol Chem 279: 24976-24985.
58. Heo TH, Lee SM, Bartosch B, Cosset FL, Kang CY (2006) Hepatitis C virus E2 links soluble human CD81 and SR-B1 protein. Virus Res 121: 58-64.
59. Grove J, Huby T, Stamataki Z, Vanwolleghem T, Meuleman P, et al. (2007) Scavenger receptor BI and BII expression levels modulate hepatitis C virus infectivity. J Virol 81: 3162-3169.
60. Harder CJ, Vassiliou G, McBride HM, McPherson R (2006) Hepatic SR-BI-mediated cholesteryl ester selective uptake occurs with unaltered efficiency in the absence of cellular energy. J Lipid Res 47: 492-503.
61. Wustner D, Mondal M, Huang A, Maxfield FR (2004) Different transport routes for high density lipoprotein and its associated free sterol in polarized hepatic cells. J Lipid Res 45: 427-437.
62. Rhainds D, Bourgeois P, Bourret G, Huard K, Falstrault L, et al. (2004) Localization and regulation of SR-BI in membrane rafts of HepG2 cells. J Cell Sci 117: 3095-3105.
63. Babitt J, Trigatti B, Rigotti A, Smart EJ, Anderson RG, et al. (1997) Murine SR-BI, a high density lipoprotein receptor that mediates selective lipid uptake, is N-glycosylated and fatty acylated and colocalizes with plasma membrane caveolae. J Biol Chem 272: 13242-13249.
64. Subbaiah PV, Gesquiere LR, Wang K (2005) Regulation of the selective uptake of cholesteryl esters from high density lipoproteins by sphingomyelin. J Lipid Res 46: 2699-2705.
65. de la Llera-Moya M, Rothblat GH, Connelly MA, Kellner-Weibel G, Sakr SW, et al. (1999) Scavenger receptor BI (SR-BI) mediates free cholesterol flux independently of HDL tethering to the cell surface. J Lipid Res 40: 575-580.
66. Marsh M, Helenius A (2006) Virus entry: open sesame. Cell 124: 729-740.
67. Zhang Y, Ahmed AM, McFarlane N, Capone C, Boreham DR, et al. (2007) Regulation of SR-BI-mediated selective lipid uptake in Chinese hamster ovary-derived cells by protein kinase signaling pathways. J Lipid Res 48: 405-416.
68. Stiasny K, Heinz FX (2004) Effect of membrane curvature-modifying lipids on membrane fusion by tick-borne encephalitis virus. J Virol 78: 8536-8542.
69. Umashankar M, Sanchez-San Martin C, Liao M, Reilly B, Guo A, et al. (2008) Differential cholesterol binding by class II fusion proteins determines membrane fusion properties. J Virol 82: 9245-9253.
70. Rawat SS, Viard M, Gallo SA, Rein A, Blumenthal R, et al. (2003) Modulation of entry of enveloped viruses by cholesterol and sphingolipids (Review). Mol Membr Biol 20: 243-254.
71. Garcia A, Barbaras R, Collet X, Bogyo A, Chap H, et al. (1996) High-density lipoprotein 3 receptor-dependent endocytosis pathway in a human hepatoma cell line (HepG2). Biochemistry 35: 13064-13071.
72. Kapadia SB, Barth H, Baumert T, McKeating JA, Chisari FV (2007) Initiation of HCV Infection is Dependent on Cholesterol and Cooperativity Between CD81 and Scavenger Receptor B Type I. J Virol 81: 374-383.
73. Yalaoui S, Huby T, Franetich JF, Gego A, Rametti A, et al. (2008) Scavenger receptor BI boosts hepatocyte permissiveness to Plasmodium infection. Cell Host Microbe 4: 283-292.
74. Rodrigues CD, Hannus M, Prudencio M, Martin C, Goncalves LA, et al. (2008) Host scavenger receptor SR-BI plays a dual role in the establishment of malaria parasite liver infection. Cell Host Microbe 4: 271-282.
75. Silvie O, Rubinstein E, Franetich JF, Prenant M, Belnoue E, et al. (2003) Hepatocyte CD81 is required for Plasmodium falciparum and Plasmodium yoelii sporozoite infectivity. Nat Med 9: 93-96.
76. de Grooth GJ, Klerkx AH, Stroes ES, Stalenhoef AF, Kastelein JJ, et al. (2004) A review of CETP and its relation to atherosclerosis. J Lipid Res 45: 1967-1974.
77. Reaven E, Cortez Y, Leers-Sucheta S, Nomoto A, Azhar S (2004) Dimerization of the scavenger receptor class B type I: formation, function, and localization in diverse cells and tissues. J Lipid Res 45: 513-528.
78. Nakabayashi H, Taketa K, Miyano K, Yamane T, Sato J (1982) Growth of human hepatoma cells lines with differentiated functions in chemically defined medium. Cancer Res 42: 3858-3863.
79. Catalano G, Duchene E, Julia Z, Le Goff W, Bruckert E, et al. (2008) Cellular SR-BI and ABCA1-mediated cholesterol efflux are gender-specific in healthy subjects. J Lipid Res 49: 635-643.
80. Oquendo P, Hundt E, Lawler J, Seed B (1989) CD36 directly mediates cytoadherence of Plasmodium falciparum parasitized erythrocytes. Cell 58: 95-101.
81. Sandrin V, Boson B, Salmon P, Gay W, Nègre D, et al. (2002) Lentiviral vectors pseudotyped with a modified RD114 envelope glycoprotein show increased stability in sera and augmented transduction of primary lymphocytes and CD34+ cells derived from human and non-human primates. Blood 100: 823-832.
82. Nègre D, Mangeot P, Duisit G, Blanchard S, Vidalain P, et al. (2000) Characterization of novel safe lentiviral vectors derived from simian immunodeficiency virus (SIVmac251) that efficiently transduce mature human dendritic cells. Gene Ther 7: 1613-1623.
83. Delgrange D, Pillez A, Castelain S, Cocquerel L, Rouille Y, et al. (2007) Robust production of infectious viral particles in Huh-7 cells by introducing mutations in hepatitis C virus structural proteins. J Gen Virol 88: 2495-2503.
84. Qin XF, An DS, Chen IS, Baltimore D (2003) Inhibiting HIV-1 infection in human T cells by lentiviral-mediated delivery of small interfering RNA against CCR5. Proc Natl Acad Sci U S A 100: 183-188.